SCN4A and neonatal diabetes mellitus: In general, gain-of-function mutations in SCN4A that enhance activation and impair inactivation of the mutant NaV1.4 channel are associated with SCM and the clinical continuum NDM/hyperPP, respectively, whereas loss-of-function mutations that drastically enhance inactivation are associated with myasthenic and myopathic-like phenotypes7.